Suppr超能文献

Petasis-Ferrier偶联/重排策略的发展:具有普遍存在的顺式-2,6-二取代四氢吡喃结构单元的结构复杂天然产物的构建。

Evolution of the Petasis-Ferrier union/rearrangement tactic: construction of architecturally complex natural products possessing the ubiquitous cis-2,6-substituted tetrahydropyran structural element.

作者信息

Smith Amos B, Fox Richard J, Razler Thomas M

机构信息

Department of Chemistry, Monell Chemical Senses Center, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

出版信息

Acc Chem Res. 2008 May;41(5):675-87. doi: 10.1021/ar700234r.

Abstract

The frequent low abundance of architecturally complex natural products possessing significant bioregulatory properties mandates the development of rapid, efficient, and stereocontrolled synthetic tactics, not only to provide access to the biologically rare target but also to enable elaboration of analogues for the development of new therapeutic agents with improved activities and/or pharmacokinetic properties. In this Account, the genesis and evolution of the Petasis-Ferrier union/rearrangement tactic, in the context of natural product total syntheses, is described. The reaction sequence comprises a powerful tactic for the construction of the 2,6- cis-substituted tetrahydropyran ring system, a ubiquitous structural element often found in complex natural products possessing significant bioactivities. The three-step sequence, developed in our laboratory, extends two independent methods introduced by Ferrier and Petasis and now comprises: condensation between a chiral, nonracemic beta-hydroxy acid and an aldehyde to furnish a dioxanone; carbonyl olefination; and Lewis-acid-induced rearrangement of the resultant enol acetal to generate the 2,6- cis-substituted tetrahydropyranone system in a highly stereocontrolled fashion. To demonstrate the envisioned versatility and robustness of the Petasis-Ferrier union/rearrangement tactic in complex molecule synthesis, we exploited the method as the cornerstone in our now successful total syntheses of (+)-phorboxazole A, (+)-zampanolide, (+)-dactylolide, (+)-spongistatins 1 and 2, (-)-kendomycin, (-)-clavosolide A, and most recently, (-)-okilactomycin. Although each target comprises a number of synthetic challenges, this Account focuses on the motivation, excitement, and frustrations associated with the evolution and implementation of the Petasis-Ferrier union/rearrangement tactic. For example, during our (+)-phorboxazole A endeavor, we recognized and exploited the inherent pseudo symmetry of the 2,6- cis-substituted tetrahydropyranone product to overcome the inherent chelation bias of an adjacent oxazolidine ring during the Lewis-acid-promoted rearrangement. In addition, we discovered that a more concentrated solution of Cp2TiMe2 (0.7 versus 0.5 M in THF) with the addition of ethyl pivalate dramatically improves the yield in the Petasis-Tebbe olefination. During the (+)-zampanolide and (+)-dactylolide programs, we observed that the addition of trifluoromethanesulfonic acid (TfOH), especially on a preparative scale, was crucial to the efficiency of the initial condensation/union reaction, while our efforts toward (-)-kendomycin led to the improved implementation of a modified Kurihara condensation of the beta-hydroxy acid and aldehyde involving i-PrOTMS and TMSOTf. Finally, the successful deployment of the Petasis-Ferrier tactic in our synthesis of (-)-clavosolide A validated the viability of this tactic with a system possessing the highly acid-labile cyclopropylcarbinyl moiety, while the challenges en route to (-)-okilactomycin demonstrated that a neighboring alkene functionality can participate in an intramolecular Prins cyclization during the TMSOTf-promoted union process, unless suitably protected.

摘要

具有重要生物调节特性的结构复杂的天然产物常常含量低且丰度小,这就需要开发快速、高效且具有立体控制性的合成策略,不仅是为了能够获得生物学上稀有的目标产物,也是为了能够合成类似物,以开发出活性和/或药代动力学性质得到改善的新型治疗药物。在本综述中,我们描述了在天然产物全合成背景下Petasis-Ferrier偶联/重排策略的起源和发展。该反应序列是构建2,6-顺式取代四氢吡喃环系统的有效策略,这种结构单元在具有重要生物活性的复杂天然产物中普遍存在。我们实验室开发的三步反应序列,扩展了Ferrier和Petasis提出的两种独立方法,现在包括:手性、非外消旋β-羟基酸与醛之间的缩合反应以生成二氧杂环己酮;羰基烯化反应;以及路易斯酸诱导所得烯醇缩醛重排,以高度立体控制的方式生成2,6-顺式取代的四氢吡喃酮系统。为了证明Petasis-Ferrier偶联/重排策略在复杂分子合成中所设想的多功能性和稳健性,我们将该方法作为基石,成功完成了(+)-佛波沙唑A、(+)-赞帕诺内酯、(+)-指状内酯、(+)-海绵他汀1和2、(-)-肯多霉素、(-)-克拉沃索内酯A以及最近的(-)-奥基拉霉素的全合成。尽管每个目标都包含许多合成挑战,但本综述重点关注与Petasis-Ferrier偶联/重排策略的发展和实施相关的动机、兴奋点和挫折。例如,在我们合成(+)-佛波沙唑A的过程中,我们认识并利用了2,6-顺式取代四氢吡喃酮产物固有的假对称性,以克服路易斯酸促进的重排过程中相邻恶唑烷环固有的螯合偏向。此外,我们发现,在加入新戊酸的情况下,更浓的二茂钛甲基溶液(四氢呋喃中浓度为0.7 M而非0.5 M)能显著提高Petasis-Tebbe烯化反应的产率。在(+)-赞帕诺内酯和(+)-指状内酯合成项目中,我们观察到加入三氟甲磺酸(TfOH),尤其是在制备规模上,对初始缩合/偶联反应的效率至关重要,而我们合成(-)-肯多霉素的努力促使改进了涉及异丙基三甲基硅氧基(i-PrOTMS)和三甲基硅基三氟甲磺酸酯(TMSOTf)的β-羟基酸与醛的改良栗原缩合反应。最后,Petasis-Ferrier策略在我们合成(-)-克拉沃索内酯A中的成功应用,验证了该策略在具有高度酸不稳定环丙基甲基部分的体系中的可行性,而在合成(-)-奥基拉霉素过程中遇到的挑战表明,除非进行适当保护,相邻的烯烃官能团在TMSOTf促进的偶联过程中会参与分子内普林斯环化反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验